Article info
Abstract
Free Communications
HPV16 LONG PEPTIDE VACCINE IS SAFE AND INDUCES STRONG TYPE 1 T-CELL IMMUNITY IN PATIENTS WITH END-STAGE CERVICAL CANCER
Citation
HPV16 LONG PEPTIDE VACCINE IS SAFE AND INDUCES STRONG TYPE 1 T-CELL IMMUNITY IN PATIENTS WITH END-STAGE CERVICAL CANCER
Online issue publication
December 03, 2018
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2004 IGCS